The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

REMINYL XL 16 mg prolonged-release capsules

16 milligram(s) Prolonged-release capsule

LTT Pharma LimitedPPA1562/113/002

Main Information

Trade NameREMINYL XL 16 mg prolonged-release capsules
Strength16 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/113/002

Group Information

ATC CodeN06DA Anticholinesterases
N06DA04 galantamine


Withdrawn Date14/01/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back